Back
Day Range
$31.85
$33.93
52-Week Range
$5.35
$40.22
Volume
409,419
50D / 200D Avg
$32.73
/
$24.99
Prev Close
$33.40
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -276.5 | 0.3 |
| P/B | 5.4 | 2.9 |
| ROE % | -2.4 | 3.7 |
| Net Margin % | -3.7 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$42.75
+32.8%
Low: $35.00
High: $60.00
Forward EPS
-$3.38
Est. Revenue
27 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.08
$0.00 – $0.18
|
340 M | 6 |
| FY2028 |
-$2.15
-$3.43 – -$0.69
|
120 M | 8 |
| FY2027 |
-$3.16
-$3.77 – -$2.05
|
49 M | 9 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Generating 44.92M in free cash flow
Capital efficient — spends only 0.36% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)404.50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-2.37%
ROIC-4.38%
Net Margin-3.73%
Op. Margin-11.16%
Safety
Debt / Equity
0.00
Current Ratio5.28
Interest Coverage-1.50
Valuation
P/E Ratio
-276.47
P/B Ratio5.40
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 404.50% | Revenue Growth (3Y) | 358.31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 184.42M | Net Income (TTM) | -6.89M |
| ROE | -2.37% | ROA | -1.65% |
| Gross Margin | 100.00% | Operating Margin | -11.16% |
| Net Margin | -3.73% | Free Cash Flow (TTM) | 44.92M |
| ROIC | -4.38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 5.28 |
| Interest Coverage | -1.50 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -276.47 | P/B Ratio | 5.40 |
| P/S Ratio | 10.32 | PEG Ratio | 2.94 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.90B | Enterprise Value | 1.82B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 184.42M | 36.56M | 8.78M | 12.41M | 0.0 |
| Net Income | -6.89M | -88.98M | -104.70M | -101.07M | -85.81M |
| EPS (Diluted) | -0.12 | -1.65 | -2.38 | -2.60 | -2.34 |
| Gross Profit | 184.42M | 36.56M | 8.78M | 12.41M | 0.0 |
| Operating Income | -20.59M | -101.37M | -114.77M | -104.36M | -86.07M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 418.43M | 271.56M | 228.34M | 256.07M | 238.87M |
| Total Liabilities | 65.98M | 42.53M | 68.78M | 71.22M | 21.09M |
| Shareholders' Equity | 352.46M | 229.02M | 159.57M | 184.85M | 217.78M |
| Total Debt | 0.0 | 2.32M | 2.06M | 2.36M | 1.51M |
| Cash & Equivalents | 84.22M | 127.98M | 191.44M | 113.56M | 144.90M |
| Current Assets | 305.70M | 232.76M | 215.34M | 244.07M | 229.22M |
| Current Liabilities | 57.88M | 40.06M | 30.82M | 31.39M | 17.14M |